skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Lung Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial

Rosell, Rafael ; Gómez-Codina, José ; Camps, Carlos ; Javier Sánchez, José ; Maestre, José ; Padilla, José ; Cantó, Antonio ; Abad, Albert ; Roig, Jordi

Lung cancer (Amsterdam, Netherlands), 1999-10, Vol.26 (1), p.7-14 [Periódico revisado por pares]

Shannon: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
2
The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer
The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer

Sas-Korczynska, Beata ; Sokolowski, Andrzej ; Korzeniowski, Stanislaw

Lung cancer (Amsterdam, Netherlands), 2013-01, Vol.79 (1), p.14-19 [Periódico revisado por pares]

Oxford: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
3
Carboplatin plus epirubicin plus VP-16, concurrent ‘split course’ radiotherapy and adjuvant surgery for limited small cell lung cancer
Carboplatin plus epirubicin plus VP-16, concurrent ‘split course’ radiotherapy and adjuvant surgery for limited small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Carboplatin plus epirubicin plus VP-16, concurrent ‘split course’ radiotherapy and adjuvant surgery for limited small cell lung cancer

Gridelli, Cesare ; D'Aprile, Modesto ; Curcio, Carlo ; Brancaccio, Luigi ; Palmeri, Sergio ; Comella, Giuseppe ; Veltri, Enzo ; Ferrante, Giovanni ; Gentile, Maria ; Rossi, Antonio ; Arcangeli, Giorgio ; Montella, Maurizio ; Raffaele Bianco, A.

Lung cancer (Amsterdam, Netherlands), 1994-07, Vol.11 (1), p.83-91 [Periódico revisado por pares]

Shannon: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
4
Radiotherapy in small-cell lung cancer: Where should it go?
Radiotherapy in small-cell lung cancer: Where should it go?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Radiotherapy in small-cell lung cancer: Where should it go?

Paumier, Amaury ; Le Péchoux, Cécile

Lung cancer (Amsterdam, Netherlands), 2010-08, Vol.69 (2), p.133-140 [Periódico revisado por pares]

Oxford: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
5
Sequential treatment with vindesine–ifosfamide–platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: A phase II trial
Sequential treatment with vindesine–ifosfamide–platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: A phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sequential treatment with vindesine–ifosfamide–platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: A phase II trial

Van den Brande, P ; De Ruysscher, D ; Vansteenkiste, J ; Spaas, Ph ; Specenier, P ; Demedts, M

Lung cancer (Amsterdam, Netherlands), 1998-10, Vol.22 (1), p.45-53 [Periódico revisado por pares]

Shannon: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
6
Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control
Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control
Material Type:
Artigo 		Adicionar ao Meu Espaço

Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control

Videtic, Gregory M.M ; Fung, Karen ; Tomiak, Anna T ; Stitt, Larry W ; Dar, A.Rashid ; Truong, Pauline T ; Yu, Edward W ; Vincent, Mark D ; Kocha, Walter I

Lung cancer (Amsterdam, Netherlands), 2001-08, Vol.33 (2), p.249-258 [Periódico revisado por pares]

Shannon: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
7
Non-small cell lung carcinoma of the superior sulcus: Favourable outcomes of combined modality treatment in carefully selected patients
Non-small cell lung carcinoma of the superior sulcus: Favourable outcomes of combined modality treatment in carefully selected patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Non-small cell lung carcinoma of the superior sulcus: Favourable outcomes of combined modality treatment in carefully selected patients

Kappers, I ; Belderbos, J.S.A ; Burgers, J.A ; van Zandwijk, N ; Groen, H.J.M ; Klomp, H.M

Lung cancer (Amsterdam, Netherlands), 2008-03, Vol.59 (3), p.385-390 [Periódico revisado por pares]

Ireland: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
8
Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?
Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?

Numico, Gianmauro ; Russi, Elvio ; Merlano, Marco

Lung Cancer, 2001-06, Vol.32 (3), p.213-226 [Periódico revisado por pares]

Shannon: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
9
The value of [ 18F]fluoro-2-deoxy- d-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment
The value of [ 18F]fluoro-2-deoxy- d-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

The value of [ 18F]fluoro-2-deoxy- d-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment

Hoekstra, C.J ; Stroobants, S.G ; Hoekstra, O.S ; Vansteenkiste, J ; Biesma, B ; Schramel, F.J.H.M ; van Zandwijk, N ; van Tinteren, H ; Smit, E.F

Lung cancer (Amsterdam, Netherlands), 2003-02, Vol.39 (2), p.151-157 [Periódico revisado por pares]

Ireland: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
10
Concomitant brain radiotherapy and vinorelbine–ifosfamide–cisplatin chemotherapy in brain metastases of non-small cell lung cancer
Concomitant brain radiotherapy and vinorelbine–ifosfamide–cisplatin chemotherapy in brain metastases of non-small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Concomitant brain radiotherapy and vinorelbine–ifosfamide–cisplatin chemotherapy in brain metastases of non-small cell lung cancer

Quantin, Xavier ; Khial, Farid ; Reme-Saumon, Monique ; Michel, François-Bernard ; Pujol, Jean-Louis

Lung cancer (Amsterdam, Netherlands), 1999-10, Vol.26 (1), p.35-39 [Periódico revisado por pares]

Shannon: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.